Skip to main content
. 2021 May 18;16(5):e0251361. doi: 10.1371/journal.pone.0251361

Table 1. Number of tested samples, RSV positivity, subtype prevalence, and demographic data from each year and the whole study period.

2016 n (%) 2017 n (%) 2018 n (%) 2016–18 n (%)
General data
Sample n° 251/632 (40%) 135/632 (21%) 246/632 (39%) 632/632 (100%)
RSV + 155/251 (62%) 80/135 (59%) 117/246 (48%) 352/632 (56%)
RSV - 96/251 (38%) 55/135 (41%) 129/246 (52%) 280/632 (44%)
Flu + 27/251 (11%) 6/135 (4%) 14/246 (6%) 47/632 (7%)
RSV+ deaths 6/155 (4%) 5/80 (6%) 3/117 (3%) 14/352 (4%)
Subtyped samples 141/155 (91%) 78/80 (98%) 113/117 (97%) 332/352 (94%)
Subtypes
RSV-A 58/141 (41%) 14/78 (18%) 108/113 (96%) 180/352 (51%)
RSV-B 80/141 (57%) 63/78 (81%) 4/113 (4%) 147/352 (42%)
RSV-A and RSV-B 3/141 (2%) 1/78 (1%) 1/113 (1%) 5/352 (1.4%)
Demographic data (RSV+)
Median age (months) 4 (1–12.0) 4 (1–10.5) 3 (1–8.0) 4 (1–11.0)
Gender
Male 72/155 (46%) 49/80 (61%) 61/117 (52%) 182/352 (52%)